Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
| dc.contributor.author | Saadati, Hassan | |
| dc.contributor.author | Baradaran, Hamid Reza | |
| dc.contributor.author | Danaei, Goodarz | |
| dc.contributor.author | Ostovar, Afshin | |
| dc.contributor.author | Hadaegh, Farzad | |
| dc.contributor.author | Janani, Leila | |
| dc.contributor.author | Steyerberg, Ewout W. | |
| dc.contributor.author | Khalili, Davood | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2021-01-04T12:01:01Z | |
| dc.date.available | 2021-01-04T12:01:01Z | |
| dc.date.issued | 2020-11-04 | |
| dc.description | Acknowledgements This study was conducted at the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences Tehran, Iran. Lown Scholar Program of the Harvard T.H. Chan School of Public Health helped in funding and designing the study. We thank the respectful staff of the Non-Communicable Diseases Office of the Ministry of Health and Medical Education in Iran for their help and advice on developing the survey. We gratefully thank Prof. MA Puhan for sharing their experience on the design and implementation of best-worst scaling. Funding This study is a part of a project funded by the National Institute of Medical Research. Development (NIMAD) (Grant No. 964114) and was supported by the Iran University of Medical. Sciences. The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 11 | |
| dc.format.extent | 1150250 | |
| dc.identifier | 184949098 | |
| dc.identifier | 85cb285f-a4c1-4527-8cad-64a1730b313e | |
| dc.identifier | 85094957074 | |
| dc.identifier | 33148227 | |
| dc.identifier.citation | Saadati, H, Baradaran, H R, Danaei, G, Ostovar, A, Hadaegh, F, Janani, L, Steyerberg, E W & Khalili, D 2020, 'Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease', BMC Medical Informatics and Decision Making, vol. 20, 288. https://doi.org/10.1186/s12911-020-01304-w | en |
| dc.identifier.doi | 10.1186/s12911-020-01304-w | |
| dc.identifier.issn | 1472-6947 | |
| dc.identifier.other | ORCID: /0000-0002-5070-5864/work/86449867 | |
| dc.identifier.uri | https://hdl.handle.net/2164/15582 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85094957074&partnerID=8YFLogxK | en |
| dc.identifier.vol | 20 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | BMC Medical Informatics and Decision Making | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Benefit harm outcomes | en |
| dc.subject | Cardiovascular disease | en |
| dc.subject | Preferences | en |
| dc.subject | Primary prevention | en |
| dc.subject | Statins | en |
| dc.subject | R Medicine | en |
| dc.subject | Health Policy | en |
| dc.subject | Health Informatics | en |
| dc.subject | Other | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Saadati_IranianGeneralPopulationsAndHealthCareProviders_VOR.pdf
- Size:
- 1.1 MB
- Format:
- Adobe Portable Document Format
